Cibc Private Wealth Group, LLC Astrazeneca PLC Transaction History
Cibc Private Wealth Group, LLC
- $50.1 Billion
- Q1 2024
A detailed history of Cibc Private Wealth Group, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 9,294,783 shares of AZN stock, worth $725 Million. This represents 1.26% of its overall portfolio holdings.
Number of Shares
9,294,783
Previous 10,424,914
10.84%
Holding current value
$725 Million
Previous $702 Million
10.31%
% of portfolio
1.26%
Previous 1.51%
Shares
30 transactions
Others Institutions Holding AZN
# of Institutions
1,244Shares Held
477MCall Options Held
5.99MPut Options Held
5.24M-
Price T Rowe Associates Inc Baltimore, MD61.3MShares$4.78 Billion0.51% of portfolio
-
Wellington Management Group LLP Boston, MA49.1MShares$3.83 Billion0.6% of portfolio
-
Primecap Management CO Pasadena, CA42.9MShares$3.35 Billion2.21% of portfolio
-
Capital International Investors Los Angeles, CA34.5MShares$2.69 Billion0.48% of portfolio
-
Jennison Associates LLC17.3MShares$1.35 Billion0.79% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $242B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...